Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00424

Submission Number:
00424
Commenter:
Pandu Jonnalagadda
State:
New York
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
By allowing the merger of two mega PBMS CVS care mark and Aetna makes the access and affordable choices very,very limited to health care consumer. Creation of SUPER MEGA PBM with unlimited power will not help the poor or middle class consumer.The Mega PBM will have the power of a MONOPOLY. I strongly believe in the best interest of healthcare consumer ,we need more choices with more options ,at an affordable price range. Many of the Retired people already dealing with limited income and increasing health care needs and decreasing choices. FTC should strongly consider not to allow this merger.We have consumers who are fast approaching 90-100 yrs.There is a great necessity for enough competition and choice at an affordable price.